Which pricing model is generally higher than the 340B price?

The Wholesale Acquisition Cost (WAC) is the correct choice because it represents the manufacturer’s list price for a drug to wholesalers or direct purchasers, excluding discounts and rebates. WAC can be seen as a benchmark price for drugs before any additional pricing arrangements come into play, such as negotiated discounts or markups that might be available in different purchasing circumstances.

The 340B price, on the other hand, is significantly lower due to the program's intent to allow eligible healthcare organizations to purchase medications at reduced prices. The WAC is typically higher than the 340B price, as the latter is specifically designed to assist certain healthcare providers in extending their resources.

Other options do not generally reflect a consistent comparison to the 340B price:

• Average Wholesale Price (AWP) is a different pricing model often used in the industry but may not directly correlate to the specific conditions and pricing that 340B entails.

• Insured Price can vary greatly depending on insurance agreements and patient coverage, making it less reliable for comparison.

• Retail Price tends to fluctuate based on local market conditions and the establishing of pharmacy pricing strategies, which may not consistently align with the structured lower prices of the 340B program.

Thus, WAC stands out as the most